Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma

Salivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer...

Full description

Bibliographic Details
Main Authors: Takayoshi Suzuki, Satoshi Kano, Masanobu Suzuki, Shinichiro Yasukawa, Takatsugu Mizumachi, Nayuta Tsushima, Kanako C. Hatanaka, Yutaka Hatanaka, Yoshihiro Matsuno, Akihiro Homma
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/full
id doaj-8e29fac9cffc4f738a08d63fbb703c93
record_format Article
spelling doaj-8e29fac9cffc4f738a08d63fbb703c932021-02-22T05:26:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.603717603717Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic AdenomaTakayoshi Suzuki0Satoshi Kano1Masanobu Suzuki2Shinichiro Yasukawa3Takatsugu Mizumachi4Nayuta Tsushima5Kanako C. Hatanaka6Yutaka Hatanaka7Yoshihiro Matsuno8Akihiro Homma9Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanClinical Research & Medical Innovation Center, Hokkaido University Hospital, Sapporo, JapanDepartment of Surgical Pathology, Hokkaido University Hospital, Sapporo, JapanDepartment of Surgical Pathology, Hokkaido University Hospital, Sapporo, JapanDepartment of Otolaryngology-Head and Neck Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, JapanSalivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer have been reported, with significant differences in HER2 expression between Ca-ex-PA and de novo. We assessed the differences in gene expression between onset classifications. We conducted immunohistochemical analysis and HER2-DISH for 23 patients and classified SDCs into three subtypes as follows: “HER2-positive” (HER2+/any AR), “Luminal-AR” (HER2-/AR+), and “Basal-like” (HER2-/AR-). We assessed the expression levels of 84 functional genes for 19 patients by using a qRT-PCR array. Ten cases were classified as HER2-positive, seven cases as Luminal-AR, and six cases as Basal-like. The gene expression pattern was generally consistent with the corresponding immunostaining classification. The expression levels of VEGFA, ERBB2(HER2), IGF1R, RB1, and XBP1 were higher, while those of SLIT2 and PTEN were lower in Ca-ex-PA than in de novo. The functions of those genes were concentrated in angiogenesis and AKT/PI3K signaling pathway (Fisher’s test: p-value = 0.025 and 0.004, respectively). Multiple machine learning methods, OPLS-DA, LASSO, and RandomForest, also show that VEGFA can be a candidate for the characteristic differences between Ca-ex-PA and de novo. In conclusion, the AKT/PI3K signaling pathway leading to angiogenesis was hyper-activated in all SDCs, particularly in those classified into the Ca-ex-PAs. VEGFA was over-expressed significantly in the Ca-ex-PA, which can be a crucial factor in the malignant conversion to SDC.https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/fullsalivary duct carcinomacarcinoma ex-pleomorphic adenomaVEGFAHER2machine learning
collection DOAJ
language English
format Article
sources DOAJ
author Takayoshi Suzuki
Satoshi Kano
Masanobu Suzuki
Shinichiro Yasukawa
Takatsugu Mizumachi
Nayuta Tsushima
Kanako C. Hatanaka
Yutaka Hatanaka
Yoshihiro Matsuno
Akihiro Homma
spellingShingle Takayoshi Suzuki
Satoshi Kano
Masanobu Suzuki
Shinichiro Yasukawa
Takatsugu Mizumachi
Nayuta Tsushima
Kanako C. Hatanaka
Yutaka Hatanaka
Yoshihiro Matsuno
Akihiro Homma
Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
Frontiers in Oncology
salivary duct carcinoma
carcinoma ex-pleomorphic adenoma
VEGFA
HER2
machine learning
author_facet Takayoshi Suzuki
Satoshi Kano
Masanobu Suzuki
Shinichiro Yasukawa
Takatsugu Mizumachi
Nayuta Tsushima
Kanako C. Hatanaka
Yutaka Hatanaka
Yoshihiro Matsuno
Akihiro Homma
author_sort Takayoshi Suzuki
title Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
title_short Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
title_full Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
title_fullStr Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
title_full_unstemmed Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
title_sort enhanced angiogenesis in salivary duct carcinoma ex-pleomorphic adenoma
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-02-01
description Salivary duct carcinoma (SDC) is morphologically similar to breast cancer, with HER2-overexpression reported. With regard to the pattern of disease onset, SDC can arise from de novo or carcinoma ex-pleomorphic adenoma (Ca-ex-PA). Recently, multiple molecular profiles of SDC as well as breast cancer have been reported, with significant differences in HER2 expression between Ca-ex-PA and de novo. We assessed the differences in gene expression between onset classifications. We conducted immunohistochemical analysis and HER2-DISH for 23 patients and classified SDCs into three subtypes as follows: “HER2-positive” (HER2+/any AR), “Luminal-AR” (HER2-/AR+), and “Basal-like” (HER2-/AR-). We assessed the expression levels of 84 functional genes for 19 patients by using a qRT-PCR array. Ten cases were classified as HER2-positive, seven cases as Luminal-AR, and six cases as Basal-like. The gene expression pattern was generally consistent with the corresponding immunostaining classification. The expression levels of VEGFA, ERBB2(HER2), IGF1R, RB1, and XBP1 were higher, while those of SLIT2 and PTEN were lower in Ca-ex-PA than in de novo. The functions of those genes were concentrated in angiogenesis and AKT/PI3K signaling pathway (Fisher’s test: p-value = 0.025 and 0.004, respectively). Multiple machine learning methods, OPLS-DA, LASSO, and RandomForest, also show that VEGFA can be a candidate for the characteristic differences between Ca-ex-PA and de novo. In conclusion, the AKT/PI3K signaling pathway leading to angiogenesis was hyper-activated in all SDCs, particularly in those classified into the Ca-ex-PAs. VEGFA was over-expressed significantly in the Ca-ex-PA, which can be a crucial factor in the malignant conversion to SDC.
topic salivary duct carcinoma
carcinoma ex-pleomorphic adenoma
VEGFA
HER2
machine learning
url https://www.frontiersin.org/articles/10.3389/fonc.2020.603717/full
work_keys_str_mv AT takayoshisuzuki enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT satoshikano enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT masanobusuzuki enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT shinichiroyasukawa enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT takatsugumizumachi enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT nayutatsushima enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT kanakochatanaka enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT yutakahatanaka enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT yoshihiromatsuno enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
AT akihirohomma enhancedangiogenesisinsalivaryductcarcinomaexpleomorphicadenoma
_version_ 1724257028180803584